UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 269

Sortiert nach

Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients

Journal of neurology, 2014-06, Vol.261 (6), p.1170-1177

2014

Volltextzugriff (PDF)

Efficacy of High-Intensity Aerobic Exercise on Brain MRI Measures in Multiple Sclerosis

Neurology, 2021-01, Vol.96 (2), p.e203

2021

Volltextzugriff (PDF)

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

PloS one, 2015-06, Vol.10 (6), p.e0122686-e0122686

2015

Volltextzugriff (PDF)

Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel

PloS one, 2015-04, Vol.10 (4), p.e0119681-e0119681

2015

Volltextzugriff (PDF)

Mapping Outcomes and Registries Used in Current Danish Pharmacoepidemiological Research

Clinical epidemiology, 2022-01, Vol.14, p.521-542

2022

Volltextzugriff (PDF)

Citrullination of histone H3 interferes with HP1-mediated transcriptional repression

PLoS genetics, 2012-09, Vol.8 (9), p.e1002934

2012

Volltextzugriff (PDF)

Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosis

PloS one, 2014-06, Vol.9 (6), p.e98588-e98588

2014

Volltextzugriff (PDF)

Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES)

BMJ open, 2021-01, Vol.11 (1), p.e043699-e043699

2021

Volltextzugriff (PDF)

Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial

Pharmaceuticals (Basel, Switzerland), 2023-07, Vol.16 (8), p.1079

2023

Volltextzugriff (PDF)

Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study

Frontiers in immunology, 2023, Vol.14, p.1327947-1327947

2023

Volltextzugriff (PDF)

Expression of HERV-Fc1, a Human Endogenous Retrovirus, Is Increased in Patients with Active Multiple Sclerosis

Journal of Virology, 2012-04, Vol.86 (7), p.3713-3722

2012

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of cannabis‐based medicine in a patient population included in a randomized, placebo‐controlled, clinical trial

Clinical and translational science, 2024-01, Vol.17 (1), p.e13685-n/a

2024

Volltextzugriff (PDF)

B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity

Retrovirology, 2009-11, Vol.6 (1), p.104-104, Article 104

2009

Volltextzugriff (PDF)

Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients

PloS one, 2012, Vol.7 (9), p.e46120-e46120

2012

Volltextzugriff (PDF)

Longitudinally extensive transverse myelitis and Hepatitis C—a case report and literature review

Clinical case reports, 2021-08, Vol.9 (8), p.e04631-n/a

2021

Volltextzugriff (PDF)

The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial

Brain sciences, 2021-09, Vol.11 (9), p.1212

2021

Volltextzugriff (PDF)

Restriction genes for retroviruses influence the risk of multiple sclerosis

PloS one, 2013-09, Vol.8 (9), p.e74063-e74063

2013

Volltextzugriff (PDF)

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

PloS one, 2013-05, Vol.8 (5), p.e63480

2013

Volltextzugriff (PDF)

Onset of Motion of Sediment underneath Scour Protection around a Monopile

Journal of marine science and engineering, 2018-09, Vol.6 (3), p.100

2018

Volltextzugriff (PDF)

Aerobic Capacity Is Not Associated with Most Cognitive Domains in Patients with Multiple Sclerosis-A Cross-Sectional Investigation

Journal of clinical medicine, 2018-09, Vol.7 (9), p.272

2018

Volltextzugriff (PDF)

Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8bright Cells in multiple Sclerosis Patients

PloS one, 2012-09, Vol.7 (9), p.e46120

2012

Volltextzugriff (PDF)

Stability of cover stones around a vertical cylinder under the influence of waves and current

Coastal engineering (Amsterdam), 2019-12, Vol.154, p.103563, Article 103563

2019

Volltextzugriff (PDF)

1 – 25 von 269

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(237)
Mit Volltextzugriff
(248)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Life Sciences & Biomedicine
(155)
Humans
(127)
Male
(87)
Female
(78)
Multiple Sclerosis
(75)
Neurosciences & Neurology
(74)
Adult
(64)
Clinical Neurology
(63)
Middle Aged
(54)
Neurosciences
(49)
Neurology
(32)
Patients
(31)
Aged
(21)
Biological And Medical Sciences
(21)
Radiology, Nuclear Medicine & Medical Imaging
(20)
Medical Sciences
(19)
Adolescent
(17)
Science & Technology - Other Topics
(17)
Treatment Outcome
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(20)
European Heart Journal Cardiovascular Imaging
(17)
Multiple Sclerosis
(17)
European Heart Journal. Cardiovascular Imaging
(15)
Radiotherapy And Oncology
(14)
Neurology
(10)
Retrovirology
(6)
Acta Oncologica
(5)
Brain
(5)
Journal Of Neuroimmunology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients

Efficacy of High-Intensity Aerobic Exercise on Brain MRI Measures in Multiple Sclerosis

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel

Mapping Outcomes and Registries Used in Current Danish Pharmacoepidemiological Research

Citrullination of histone H3 interferes with HP1-mediated transcriptional repression

Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosis

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS

Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES)

Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial

Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study

Expression of HERV-Fc1, a Human Endogenous Retrovirus, Is Increased in Patients with Active Multiple Sclerosis

Pharmacokinetics and pharmacodynamics of cannabis‐based medicine in a patient population included in a randomized, placebo‐controlled, clinical trial

The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1

B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity

Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients

Longitudinally extensive transverse myelitis and Hepatitis C—a case report and literature review

The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial

Restriction genes for retroviruses influence the risk of multiple sclerosis

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

Onset of Motion of Sediment underneath Scour Protection around a Monopile

Aerobic Capacity Is Not Associated with Most Cognitive Domains in Patients with Multiple Sclerosis-A Cross-Sectional Investigation

Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8bright Cells in multiple Sclerosis Patients

Stability of cover stones around a vertical cylinder under the influence of waves and current

Suchergebnisse filtern